The clinical pharmacokinetics of darifenacin.

The clinical pharmacokinetics of darifenacin.

Item
http://www.wikidata.org/entity/Q34566180
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.Darifenacin: a muscarinic M3-selective receptor antagonist for the treatment of overactive bladder.α1-Adrenoceptors and muscarinic receptors in voiding function - binding characteristics of therapeutic agents in relation to the pharmacokinetics.A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder.Refractory overactive bladder: a common problem?Update on the management of overactive bladder: patient considerations and adherenceA short review of drug-food interactions of medicines treating overactive bladder syndrome.Novel biomarkers for overactive bladder.Safety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladder.Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females.New pharmacological approaches to the cholinergic system: an overview on muscarinic receptor ligands and cholinesterase inhibitors.Assessment of inhibitory effects on major human cytochrome P450 enzymes by spasmolytics used in the treatment of overactive bladder syndrome.Characterization of bladder selectivity of antimuscarinic agents on the basis of in vivo drug-receptor binding.QSAR models for P450 (2D6) substrate activity.Safety, tolerability and pharmacokinetics and pharmacodynamics of inhaled once-daily umeclidinium in healthy adults deficient in CYP2D6 activity: a double-blind, randomized clinical trial.Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.Method Development and Validation of Darifenacin in Rat Plasma by Liquid Chromatography-Tandem Mass Spectrometry: Application to a Pharmacokinetic Study
P2860

The clinical pharmacokinetics of darifenacin.

Item
http://www.wikidata.org/entity/Q34566180
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The clinical pharmacokinetics of darifenacin.
@ast
The clinical pharmacokinetics of darifenacin.
@en
The clinical pharmacokinetics of darifenacin.
@nl
type
label
The clinical pharmacokinetics of darifenacin.
@ast
The clinical pharmacokinetics of darifenacin.
@en
The clinical pharmacokinetics of darifenacin.
@nl
prefLabel
The clinical pharmacokinetics of darifenacin.
@ast
The clinical pharmacokinetics of darifenacin.
@en
The clinical pharmacokinetics of darifenacin.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
The clinical pharmacokinetics of darifenacin.
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/00003088-200645040-00001
P433
P478
P577
P6179
P698